Archived Facts

Shares of Orexigen Therapeutics Inc. jumped Thursday after the company said it signed a development and sales deal for the potential obesity drug Contrave with Japan’s Takeda Pharmaceutical Co. Ltd.

View full post on All News, Video and Posts related to SECTOR: Health Care

Popular Posts:

Related Posts:

Leave a Reply